Aditxt, Inc. Stock Option, Exercise Price, Decrease
Aditxt, Inc. (ADTX) reported Stock Option, Exercise Price, Decrease of $6802.93 per share for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockOptionExercisePriceDecrease · last filed 2023-11-14
- Aditxt, Inc. stock option, exercise price, decrease for the quarter ending 2023-03-31 was $172.30.
- Aditxt, Inc. stock option, exercise price, decrease for fiscal 2022 was $173.50.
| Period end | Stock Option, Exercise Price, Decrease 3 month | Stock Option, Exercise Price, Decrease 6 month | Stock Option, Exercise Price, Decrease 9 month | Stock Option, Exercise Price, Decrease 12 month |
|---|---|---|---|---|
| 2023-09-30 | $6802.93 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $171.13 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $172.30 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $173.50 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |